UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for UCSF Clinical Laboratories

Lab Manual for SFGH

Internal Resources

Scott C. Kogan, MD

Research and Clinical Interests

The Kogan laboratory aims understand the pathogenesis of acute leukemias and to apply this understanding to extend survival for patients with leukemias and other malignancies. Our scientific focus is to comprehend the alterations in cell fate decisions that govern the transformation of normal hematopoietic cells into AML or ALL. We work to identify genetic changes that contribute to leukemia, delineate how genetic changes combine at the cellular and molecular levels to cause transformation and develop improved treatments using molecularly targeted therapeutics. Clinically Dr. Kogan has a strong interest in the biology and medicine of thrombosis and hemostasis.

Selected Publications

  • Sternsdorf, T; Phan, V; Maunakea, ML; Ocampo-Bayuga, C; Sohal, J; Silletto, A; Galimi, F; LeBeau, MM; Evans, RM; Kogan, SC. Forced Retinoic Acid Receptor alpha Homodimers Prime Mice for APL-like Leukemia. Cancer Cell, 2006, 9:81-94.
  • Lee, YJ; Jones, LC; Timchenko, NA; Perrotti, D; Tenen, DG; Kogan, SC. CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but they differ in their anti-leukemic activities. Blood, 2006, 108:2416-2419.
  • Lee, BD; Sevcikova, S; Kogan, SC. Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice. Leuk Res, 2007 31:1139-1142.
  • Zuber, J; Radtke, I; Pardee, T; Zhao, Z; Rappaport AR; Luo, W; McCurrach, ME; Yang, M; Dolan, E; Kogan, SC; Downing, JR; Lowe, SW. Mouse models of human AML accurately predict chemotherapy response. Genes Dev, 2009, 23:877-889.
  • Lauchle, JO; Kim, D; Le, DT; Akagi, K; Crone, M; Krisman, K; Warner, K; Bonifas, JM; Li, Q; Coakley, KM; Diaz-Flores, E; Gorman, M; Przybranowsk,i S; Tran, M; Kogan, SC; Roose, JP; Copeland, NG; Jenkins, NA; Parada, L; Wolff, L; Sebolt-Leopold, J; Shannon, K. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature, 2009, 461:411-414.
  • Zhao, Z; Zuber, J; Diaz-Flores, E; Lintault, L; Kogan, SC; Shannon, K; Lowe, SW. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes Dev, 2010, 24:1389-1402.

Selected Awards

  • 2001: Recipient, Medical Student Teaching Award, Excellence for Small Group Instruction
  • 2003: Resident Teaching Award, Department of Laboratory Medicine
  • 2004-09: Leukemia & Lymphoma Society Scholar Award
  • 2007: Mentor Award, UCSF Department of Pediatrics
  • Professor, Assistant Chief, Clinical Hematology Laboratory Head, Clinical Coagulation Laboratory UCSF Comprehensive Cancer Center, Co-Director, Mouse Pathology Core
  • Laboratory Medicine
  • Hematology

Specialty Area

  • Hematopathology

Contact Information

  • 513 Parnassus Avenue
  • Room S-561, Box 0451
  • University of California San Francisco
  • San Francisco, CA 94143-0451

Web Site

Other UCSF Organizational Association(s)

  • UCSF Comprehensive Cancer Center, Hematopoietic Malignancies Program
  • UCSF Biomedical Sciences Graduate Program

Hospital Affiliation(s)

  • UCSF Medical Center
  • Mt. Zion
  • Moffitt-Long
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center